Investor Relations Manager

at  Basilea Pharmaceutica International

ABOUT US

Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. Basilea has about 150 employees. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial or fungal infections. We have successfully launched two hospital brands, Cresemba® for the treatment of invasive fungal infections and Zevtera® for the treatment of bacterial infections. In addition, we have preclinical anti-infective assets in our portfolio. Basilea is listed on the SIX Swiss Exchange (SIX: BSLN)

• Communicate with current and potential shareholders, analysts and other stakeholders about the company’s financial performance, strategy and opportunities as well as about the development pipeline
• Respond to investor and analyst inquiries; ensure alignment within the Finance department and with other departments such as Legal, Research and Development
• Develop and foster relations with corporate access teams and brokers by organizing roadshows
• Representing the company in investor meetings and conferences
• Ensure compliance with regulatory requirements for financial disclosure, including timely and accurate reporting
• Manage the realization of SIX-compliant annual/half-year financial reports
• Prepare earnings releases, scripts, Q&As and investor decks for earnings announcements, investor meetings and roadshows
• Plan and execute the company’s Annual General Meeting and other investor events, such as Capital Market Days, including the preparation of speeches and presentations
• Review analysts’ reports and models on analyst recommendations, price targets, consensus data, shareholder structure and share price development, and provide reports to the company’s senior management and Board of Directors; identify potential shareholders
• Support the continuous development and implementation of the Investor Relation (IR) strategy and develop investor material to convey that strategy
• Prepare the IR budget